Biopsy method comparison for diagnosing prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study compares two ways of doing prostate biopsies (sampling tissue from the prostate) to see if one is better. It is for men who have a suspicious MRI finding on one side of the prostate and have not had a biopsy before. Participation may help determine which method is more accurate and could influence future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a male aged 18 or older.
- You must be scheduled for a prostate biopsy because cancer is suspected.
- Your prostate MRI must show a suspicious area on one side of the prostate (not both sides).
- Your PSA level must be 20 ng/mL or lower.
- You must not have had a prior prostate biopsy or any prostate cancer treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to do prostate biopsies by combining MRI findings with a targeted biopsy on the same side as the suspicious area. It is for men who have not had a biopsy before and have a moderately high PSA level.
This study tests if a special MRI measurement (ADC) can improve how well a standard MRI finds prostate cancer. If you have a suspicious MRI and are scheduled for a biopsy, this might help better understand your results.
This trial compares two ways to guide a prostate biopsy using MRI images, to see which better detects clinically significant prostate cancer in men with suspicious MRI findings.
This study compares two ways of taking prostate biopsies in men with suspected prostate cancer, to see which method finds cancer more accurately. Participation may help doctors choose the best biopsy approach for future patients.
This trial compares two ways to take a prostate biopsy (through the rectum or through the skin between the scrotum and anus) to see which is more accurate. Men with suspicious MRI findings (PI-RADS 3, 4, or 5) who haven't had prostate cancer before may be eligible.
This trial compares two ways to use MRI images during a prostate biopsy to see which finds cancer better. It looks at 'fusion' biopsy (where a computer combines MRI with live ultrasound) versus 'cognitive' biopsy (where the doctor mentally matches the MRI to the ultrasound).
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.